BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 7660812)

  • 21. Effects of glaucocalyxin A on aggregation and cAMP levels of rabbit platelets in vitro.
    Zhang B; Long K
    Zhongguo Yao Li Xue Bao; 1993 Jul; 14(4):347-50. PubMed ID: 8249632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies.
    Ortega MP; García MC; Gijón MA; de Casa-Juana MF; Priego JG; Sanchez Crespo M; Sunkel C
    J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
    Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S
    Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual effects of 5-hydroxytryptamine on stable analogue of thromboxane A2-induced aggregation and release reaction in rabbit platelets.
    Li BY; Zhou YC; Li WH
    Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):171-4. PubMed ID: 10374646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of specific antagonists on PAF-induced platelet aggregation and release of plasminogen activator.
    Hofmann B; Ostermann G; Hoffmann A; Klöcking HP; Kertscher HP
    Biomed Biochim Acta; 1988; 47(10-11):S157-60. PubMed ID: 3248103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antagonistic effect of myricetin on platelet activing factor].
    Zang BX; Jin M; Wu W; Chen WM; Piao YZ; Li JR
    Yao Xue Xue Bao; 2003 Nov; 38(11):831-3. PubMed ID: 14991995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation.
    Saeed SA; Rasheed H
    Acta Pharmacol Sin; 2003 Jan; 24(1):31-6. PubMed ID: 12511226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of magnesium lithospermate B on aggregation and 5-HT release in rabbit washed platelets.
    Wang W; Wang YP; Sun WK; Xu YM; Xuan LJ
    Acta Pharmacol Sin; 2000 Sep; 21(9):859-63. PubMed ID: 11501172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory role of protein tyrosine phosphorylation in platelet activating factor-induced signal transduction in platelets.
    Zeng S; Yi FX; Guo ZG
    Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):157-61. PubMed ID: 10437164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
    Hwang SB; Lam MH; Szalkowski DM; MacIntyre DE; Bach TJ; Luell S; Meuer R; Sahoo SP; Alberts AW; Chabala JC
    J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aggregation, release and desensitization induced in platelets from five species by platelet activating factor (PAF).
    Cargill DI; Cohen DS; Van Valen RG; Klimek JJ; Levin RP
    Thromb Haemost; 1983 Jun; 49(3):204-7. PubMed ID: 6879508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of ADP-induced aggregation by 5-HT in rabbit platelets.
    Li BY; Bai Y; Li WH
    Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):58-62. PubMed ID: 10375761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-platelet activating factor property of Rubia cordifolia Linn.
    Tripathi YB; Pandey S; Shukla SD
    Indian J Exp Biol; 1993 Jun; 31(6):533-5. PubMed ID: 8406601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions].
    Nunez D; Russo-Marie F; Benveniste J
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):215. PubMed ID: 3550639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effect of the Korean herbal medicine, Dae-Jo-Whan, on platelet-activating factor-induced platelet aggregation.
    Chang GT; Kang SK; Kim JH; Chung KH; Chang YC; Kim CH
    J Ethnopharmacol; 2005 Dec; 102(3):430-9. PubMed ID: 16125889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of 6-(alpha alpha-diphenylacetylpiperazinyl) phenyl-5-methyl-4,5-dihydro-3 (2H)-pyridazinone on rabbit platelet aggregation and TXB2, cAMP production].
    Zeng GQ; Wang XS; Sun DX; Lin AY; Ji Y; Chu JX; Rui YC
    Yao Xue Xue Bao; 1993; 28(4):256-9. PubMed ID: 8213167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.
    Terashita Z; Imura Y; Takatani M; Tsushima S; Nishikawa K
    J Pharmacol Exp Ther; 1987 Jul; 242(1):263-8. PubMed ID: 3612533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of dauricine on rat and human platelet aggregation and metabolism of arachidonic acid in washed rat platelets].
    Tong L; Yue TL
    Yao Xue Xue Bao; 1989; 24(2):85-8. PubMed ID: 2801142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to platelet-activating factor (PAF) inhibit PAF-induced platelet aggregation.
    Smal MA; Cooney SJ; Baldo BA
    J Lipid Mediat; 1991 Nov; 4(3):333-41. PubMed ID: 1764578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of tetrandrine on cytosolic free calcium in cultured rat myocardial cells.
    Li XT; Wang YL; Wang JX; Yang SJ
    Zhongguo Yao Li Xue Bao; 1996 Jan; 17(1):55-8. PubMed ID: 8737455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.